Alpha 2.0
Login Register
» Articles » PMID: 30409563

Cross-Sectional Study of Temozolomide-Induced Chemotherapy-Induced Nausea and Vomiting in Patients with Glioma

Overview
Journal Clin Oncol (R Coll Radiol)
Specialty Oncology
Date 2018 Nov 10
PMID 30409563
Citations 1
Authors
M Malhotra
A Chandrasekahran
R Tonse
R Jalali
V M Patil
Affiliations
Soon will be listed here.
Citing Articles

Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide.

Patel M, Woodring S, Randazzo D, Friedman H, Desjardins A, Healy P Support Care Cancer. 2019; 28(5):2229-2238.

PMID: 31440823 DOI: 10.1007/s00520-019-05039-x.